A detailed history of Royce & Associates LP transactions in Rad Net, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 108,039 shares of RDNT stock, worth $7.07 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
108,039
Previous 171,599 37.04%
Holding current value
$7.07 Million
Previous $10.1 Million 25.86%
% of portfolio
0.07%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$55.28 - $71.1 $3.51 Million - $4.52 Million
-63,560 Reduced 37.04%
108,039 $7.5 Million
Q2 2024

Aug 13, 2024

SELL
$46.52 - $61.75 $2.14 Million - $2.84 Million
-46,061 Reduced 21.16%
171,599 $10.1 Million
Q1 2024

May 13, 2024

SELL
$33.57 - $48.66 $4.51 Million - $6.54 Million
-134,475 Reduced 38.19%
217,660 $10.6 Million
Q4 2023

Feb 12, 2024

SELL
$25.42 - $37.19 $444,850 - $650,825
-17,500 Reduced 4.73%
352,135 $12.2 Million
Q3 2023

Nov 09, 2023

BUY
$27.3 - $34.99 $456,729 - $585,382
16,730 Added 4.74%
369,635 $10.4 Million
Q2 2023

Aug 07, 2023

SELL
$25.0 - $33.44 $2.53 Million - $3.39 Million
-101,300 Reduced 22.3%
352,905 $11.5 Million
Q1 2023

May 04, 2023

SELL
$18.18 - $25.07 $230,886 - $318,389
-12,700 Reduced 2.72%
454,205 $11.4 Million
Q4 2022

May 23, 2023

BUY
$15.17 - $21.05 $192,659 - $267,335
12,700 Added 2.8%
466,905 $8.79 Million
Q4 2022

Feb 13, 2023

BUY
$15.17 - $21.05 $121,360 - $168,400
8,000 Added 1.74%
466,905 $8.79 Million
Q3 2022

Nov 03, 2022

BUY
$17.2 - $23.02 $2.65 Million - $3.55 Million
154,000 Added 50.51%
458,905 $9.34 Million
Q2 2022

Aug 04, 2022

BUY
$16.8 - $22.68 $924,000 - $1.25 Million
55,000 Added 22.01%
304,905 $5.27 Million
Q1 2022

May 05, 2022

BUY
$20.47 - $29.82 $571,113 - $831,978
27,900 Added 12.57%
249,905 $5.59 Million
Q4 2021

Feb 07, 2022

SELL
$26.37 - $34.6 $600,761 - $788,257
-22,782 Reduced 9.31%
222,005 $6.69 Million
Q3 2021

Nov 10, 2021

SELL
$27.55 - $38.15 $1.1 Million - $1.52 Million
-39,918 Reduced 14.02%
244,787 $7.18 Million
Q2 2021

Aug 06, 2021

SELL
$21.21 - $36.0 $218,463 - $370,800
-10,300 Reduced 3.49%
284,705 $9.59 Million
Q1 2021

May 10, 2021

BUY
$17.73 - $23.98 $664,875 - $899,250
37,500 Added 14.56%
295,005 $6.42 Million
Q4 2020

Feb 08, 2021

BUY
$14.51 - $19.72 $435,300 - $591,600
30,000 Added 13.19%
257,505 $5.04 Million
Q3 2020

Nov 12, 2020

BUY
$13.94 - $17.81 $99,489 - $127,109
7,137 Added 3.24%
227,505 $3.49 Million
Q2 2020

Aug 07, 2020

BUY
$8.28 - $18.6 $152,724 - $343,077
18,445 Added 9.13%
220,368 $3.5 Million
Q1 2020

May 12, 2020

SELL
$6.14 - $23.11 $1.04 Million - $3.91 Million
-169,000 Reduced 45.56%
201,923 $2.12 Million
Q4 2019

Feb 06, 2020

SELL
$13.9 - $20.33 $2.5 Million - $3.65 Million
-179,500 Reduced 32.61%
370,923 $7.53 Million
Q3 2019

Nov 13, 2019

BUY
$13.8 - $15.23 $303,600 - $335,060
22,000 Added 4.16%
550,423 $7.9 Million
Q2 2019

Aug 12, 2019

BUY
$12.06 - $13.79 $1.98 Million - $2.26 Million
164,000 Added 45.0%
528,423 $7.29 Million
Q1 2019

May 09, 2019

BUY
$10.03 - $15.86 $922,759 - $1.46 Million
92,000 Added 33.77%
364,423 $4.52 Million
Q4 2018

Feb 11, 2019

BUY
$10.17 - $16.26 $1.42 Million - $2.27 Million
139,409 Added 104.81%
272,423 $2.77 Million
Q3 2018

Nov 13, 2018

SELL
$13.4 - $15.75 $710,615 - $835,238
-53,031 Reduced 28.5%
133,014 $2 Million
Q1 2018

May 14, 2018

BUY
$9.8 - $14.4 $94,834 - $139,348
9,677 Added 5.49%
186,045 $2.68 Million
Q4 2017

Feb 09, 2018

BUY
$9.65 - $11.75 $1.48 Million - $1.81 Million
153,868 Added 683.86%
176,368 $1.78 Million
Q3 2017

Nov 13, 2017

SELL
$7.6 - $11.85 $57,000 - $88,875
-7,500 Reduced 25.0%
22,500 $260,000
Q2 2017

Aug 07, 2017

BUY
N/A
30,000
30,000 $233,000

Others Institutions Holding RDNT

About RadNet, Inc.


  • Ticker RDNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,310,000
  • Market Cap $3.75B
  • Description
  • RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modali...
More about RDNT
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.